Not Signed In -
Leuprolide |
Eligard; Lupron |
Image:Leuprolide.png Leuprolide Systematic (IUPAC) name N-[1-[[1-[[1-[[1-[[1-[[1-[[5- (diaminomethylideneamino)-1- [2-(ethylcarbamoyl)pyrrolidin-1-yl]- 1-oxo-pentan-2-yl]carbamoyl]- 3-methyl-butyl]carbamoyl]-3-methyl- butyl]carbamoyl]-2-(4-hydroxyphenyl) ethyl]carbamoyl]-2-hydroxy-ethyl] carbamoyl]-2-(1H-indol-3-yl)ethyl] carbamoyl]-2-(3H-imidazol-4-yl)ethyl]- 5-oxo-pyrrolidine-2-carboxamide Identifiers CAS number 53714-56-0 ATC code L02AE02 PubChem 441410 DrugBank BTD000 ...
Wikipedia - [full article]
Leuprolide Clinical Trials
- Leuprolide or Goserelin Plus Thalidomide Compared With Leuprolide or Goserelin Alone in Treating Patients With Nonmetastatic Prostate Cancer
ClinicalTrials.gov Identifier: NCT00020085 - Active, not recruiting
Prostate Cancer
- Leuprolide in Treating Adults With Hypogonadotropism
ClinicalTrials.gov Identifier: NCT00004438 - Recruiting
Hypogonadism
- Leuprolide in Determining the Cause of Gonadotropin Deficiency
ClinicalTrials.gov Identifier: NCT00004426 - Recruiting
Hypogonadism
- Rapid Hormone Cycling With Testosterone and Leuprolide Combined With Docetaxel in Treating Patients With Recurrent or Metastatic Adenocarcinoma (Cancer) of the Prostate
ClinicalTrials.gov Identifier: NCT00070369 - Active, not recruiting
adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer
- Phase II Randomized Study of Leuprolide vs Oral Contraceptive Therapy vs Leuprolide and Oral Contraceptive Therapy for Ovarian Hyperandrogenism
ClinicalTrials.gov Identifier: NCT00004763 - Completed
Hyperandrogenism
- Study of a 6-Month Sustained-release Formulation of Leuprolide in Prostate Cancer
ClinicalTrials.gov Identifier: NCT00056654 - Completed
Prostatic Neoplasms
- Adjuvant Leuprolide With or Without Docetaxel in High Risk Prostate Cancer After Radical Prostatectomy
ClinicalTrials.gov Identifier: NCT00283062 - Recruiting
Prostatic Neoplasms
- Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (ALADDIN) VP 104 Study
ClinicalTrials.gov Identifier: NCT00076440 - Completed
Alzheimer Disease
- Clinical Trial for Prostate Cancer
ClinicalTrials.gov Identifier: NCT00076531 - Active, not recruiting
Prostate Cancer
- A Study of Androgen Deprivation With Leuprolide, +/- Docetaxel for Clinically Asymptomatic Prostate Cancer Subjects With a Rising PSA
ClinicalTrials.gov Identifier: NCT00514917 - Recruiting
Prostatic Neoplasms
- Melanoma Vaccine With Peptides and Leuprolide
ClinicalTrials.gov Identifier: NCT00254397 - Recruiting
Melanoma
- Study of External Beam Radiation Therapy with and Without Hormonal Therapy to Treat Prostate Cancer
ClinicalTrials.gov Identifier: NCT00116220 - Active, not recruiting
Prostate Cancer
- Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
ClinicalTrials.gov Identifier: NCT00430183 - Recruiting
Prostate Cancer
- Letrozole and Goserelin or Leuprolide in Treating Premenopausal Estrogen Receptor-Positive Patients With Stage IV Breast Cancer
ClinicalTrials.gov Identifier: NCT00498901 - Recruiting
Breast Cancer
- Efficacy and Safety of Leuprolide Acetate 3.75 Mg Depot to Treat Prostate Cancer
ClinicalTrials.gov Identifier: NCT00128531 - Completed
Prostate Cancer
- Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003653 - Active, not recruiting
adenocarcinoma of the prostate; recurrent prostate cancer
- Chemotherapy and Hormone Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003915 - Active, not recruiting
adenocarcinoma of the prostate; stage I prostate cancer
- Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Operable Invasive Breast Cancer
ClinicalTrials.gov Identifier: NCT00002580 - Active, not recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
- Insulin Resistance and Testosterone in Women with Metabolic Syndrome
ClinicalTrials.gov Identifier: NCT00123110 - Recruiting
Metabolic Syndrome; Postmenopause
- Chemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients with Locally Advanced Prostate Cancer
ClinicalTrials.gov Identifier: NCT00016913 - Active, not recruiting
adenocarcinoma of the prostate; stage III prostate cancer
- Clinical Trial of Leuprolide Acetate for the Treatment of PMS
ClinicalTrials.gov Identifier: NCT00001259 - Recruiting
Depressive Disorder; Mood Disorder
- Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer
ClinicalTrials.gov Identifier: NCT00028769 - Active, not recruiting
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer
ClinicalTrials.gov Identifier: NCT00002597 - Active, not recruiting
stage II prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate
- Hormone Therapy in Treating Patients Who Have Stage I or Stage II Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003645 - Active, not recruiting
stage II prostate cancer; stage I prostate cancer
- Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00002889 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate
- Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00006359 - Active, not recruiting
adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
- Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00005044 - Active, not recruiting
adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer
- Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer
ClinicalTrials.gov Identifier: NCT00002582 - Active, not recruiting
stage II breast cancer; stage I breast cancer; stage IIIA breast cancer
- Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003394 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate; ...
- Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases
ClinicalTrials.gov Identifier: NCT00081159 - Active, not recruiting
recurrent prostate cancer; stage IV prostate cancer; bone metastases
- Hormone Therapy Plus Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003124 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate
- Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00002633 - Active, not recruiting
adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer
- SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00026377 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; adenocarcinoma of the prostate
- Bortezomib With or Without Hormone Therapy in Treating Patients With Relapsed Prostate Cancer
ClinicalTrials.gov Identifier: NCT00103376 - Recruiting
adenocarcinoma of the prostate; recurrent prostate cancer
- Phase II Study of the Effect of Leuprolide Acetate and Spironolactone on Insulin Resistance in Hyperandrogenic Women with Polycystic Ovarian Disease or Hyperandrogenism Insulin Resistance Acanthosis Nigricans Syndrome
ClinicalTrials.gov Identifier: NCT00004311 - Completed
Acanthosis Nigricans; Polycystic Ovary Syndrome
- Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse
ClinicalTrials.gov Identifier: NCT00055731 - Recruiting
stage III prostate cancer; stage II prostate cancer
- Phase II Study of Leuprolide and Testosterone for Men with Kennedy's Disease or Other Motor Neuron Disease
ClinicalTrials.gov Identifier: NCT00004771 - Completed
Spinal Muscular Atrophy; Amyotrophic Lateral Sclerosis; Spinobulbar Muscular Atrophy
- Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate Cancer
ClinicalTrials.gov Identifier: NCT00099086 - Recruiting
adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer
- Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003517 - Recruiting
adenocarcinoma of the prostate; stage III prostate cancer; stage IV prostate cancer; recurrent prostate cancer
- Randomized Study of Hormonal Regulation of Infantile Hemangioma
ClinicalTrials.gov Identifier: NCT00004436 - Completed
Hemangioma
- ALADDIN Study - Phase III: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (VP-AD-301)
ClinicalTrials.gov Identifier: NCT00231946 - Completed
Alzheimer's Disease
- ALADDIN Study
ClinicalTrials.gov Identifier: NCT00063310 - Completed
Alzheimer Disease
- Purification of Testis-Stimulating Factor in Precocious Puberty
ClinicalTrials.gov Identifier: NCT00004344 - Completed
Precocious Puberty
- A Phase II Trial of Leuprolide + Flutamide + Suramin in Untreated Poor Prognosis Prostate Carcinoma
ClinicalTrials.gov Identifier: NCT00001266 - Completed
Prostatic Neoplasm
- Pazopanib After Leuprolide or Goserelin in Treating Patients With Relapsed Prostate Cancer
ClinicalTrials.gov Identifier: NCT00454571 - Suspended
Prostate Cancer
- Hormone Therapy Followed By Internal Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer
ClinicalTrials.gov Identifier: NCT00032006 - Completed
adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; recurrent prostate cancer
- Flutamide, Suramin, and Hydrocortisone in Treating Patients with Prostate Cancer
ClinicalTrials.gov Identifier: NCT00002881 - Completed
stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer; Quality of Life
Resources
- Eligard (Drug Digest)
- Leuprolide (Drug Digest)
email this page
print this page
bookmark this page
feedback on this page
